Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,139 | 607 | 94.6% |
| Education | $504.81 | 6 | 4.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $127.95 | 8 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,106 | 68 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $874.26 | 28 | $0 (2024) |
| Lilly USA, LLC | $803.42 | 33 | $0 (2024) |
| Amgen Inc. | $728.88 | 27 | $0 (2022) |
| Lundbeck LLC | $683.05 | 37 | $0 (2024) |
| UCB, Inc. | $587.62 | 18 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $444.32 | 18 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $434.97 | 29 | $0 (2024) |
| Allergan, Inc. | $359.76 | 24 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $357.45 | 24 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,257 | 116 | ABBVIE INC. ($382.48) |
| 2023 | $2,112 | 95 | AbbVie Inc. ($360.54) |
| 2022 | $1,510 | 84 | ABBVIE INC. ($201.96) |
| 2021 | $1,529 | 95 | Lundbeck LLC ($180.68) |
| 2020 | $1,175 | 68 | Amgen Inc. ($188.94) |
| 2019 | $1,108 | 53 | Amgen Inc. ($178.78) |
| 2018 | $1,235 | 48 | Adamas Pharmaceuticals, Inc. ($173.92) |
| 2017 | $846.54 | 62 | Teva Pharmaceuticals USA, Inc. ($235.89) |
All Payment Transactions
621 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Rare Disease | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Analgesic | ||||||
| 12/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Neurology | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/18/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: NEUROLOGY | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: PAIN | ||||||
| 11/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/08/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: Neuroscience | ||||||
| 11/01/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug), VYVGART | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Neurology | ||||||
| 10/22/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Neuroscience | ||||||
| 10/21/2024 | Merz Pharmaceuticals, LLC | INBRIJA (Drug), Xeomin | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Parkinson's Disease | ||||||
| 10/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Neurology | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Analgesic | ||||||
| 10/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Neuropsychiatry | ||||||
| 10/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $4.07 | General |
| Category: Neuropsychiatry | ||||||
| 09/30/2024 | Amneal Pharmaceuticals LLC | ONGENTYS 50MG CAPSULES 30 (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: NEUROLOGY | ||||||
| 09/26/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $122.55 | General |
| Category: Neuroscience | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,205 | 9,862 | $309,865 | $204,606 |
| 2022 | 16 | 1,279 | 12,690 | $330,825 | $221,937 |
| 2021 | 18 | 1,558 | 15,648 | $406,645 | $278,750 |
| 2020 | 17 | 1,639 | 13,447 | $342,960 | $224,775 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 486 | 933 | $135,325 | $89,204 | 65.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 12 | 8,095 | $55,665 | $40,008 | 71.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 137 | 137 | $25,345 | $17,413 | 68.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 126 | 182 | $22,750 | $14,174 | 62.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 71 | 71 | $15,975 | $9,696 | 60.7% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 73 | 73 | $12,775 | $7,963 | 62.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 86 | $8,600 | $5,284 | 61.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 28 | 28 | $7,700 | $4,780 | 62.1% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 59 | 93 | $6,975 | $4,660 | 66.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $7,250 | $4,519 | 62.3% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 18 | 18 | $2,970 | $1,752 | 59.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 13 | 13 | $1,950 | $1,360 | 69.7% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 13 | 26 | $1,950 | $1,288 | 66.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 16 | 18 | $1,080 | $771.66 | 71.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 12 | 23 | $1,150 | $752.62 | 65.4% |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | Office | 2023 | 18 | 19 | $1,235 | $510.85 | 41.4% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 18 | 18 | $1,170 | $468.86 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 457 | 833 | $120,785 | $78,114 | 64.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 20 | 10,900 | $70,850 | $53,375 | 75.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 172 | 259 | $32,375 | $21,011 | 64.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 111 | 111 | $20,535 | $15,230 | 74.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 84 | 84 | $18,900 | $11,576 | 61.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 142 | $14,200 | $9,273 | 65.3% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 83 | 84 | $14,700 | $9,248 | 62.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 44 | 44 | $11,000 | $7,071 | 64.3% |
About Dr. Daniela Saadia, MD
Dr. Daniela Saadia, MD is a Neurology healthcare provider based in Stuart, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1629271390.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniela Saadia, MD has received a total of $11,772 in payments from pharmaceutical and medical device companies, with $2,257 received in 2024. These payments were reported across 621 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($11,139).
As a Medicare-enrolled provider, Saadia has provided services to 5,681 Medicare beneficiaries, totaling 51,647 services with total Medicare billing of $930,068. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Stuart, FL
- Active Since 06/08/2007
- Last Updated 02/26/2015
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629271390
Products in Payments
- Aimovig (Biological) $720.40
- Briviact (Drug) $498.07
- BOTOX (Biological) $465.56
- UBRELVY (Drug) $455.23
- QULIPTA (Drug) $444.00
- RYTARY (Drug) $431.67
- ULTOMIRIS (Biological) $424.77
- TROKENDI XR (Drug) $357.45
- EMGALITY (Drug) $351.12
- AMYVID (Drug) $329.75
- Leqembi (Drug) $301.26
- VYEPTI (Biological) $293.56
- INGREZZA (Drug) $289.69
- NURTEC ODT (Drug) $283.77
- NUEDEXTA (Drug) $282.33
- APTIOM (Drug) $282.21
- NORTHERA (Drug) $270.99
- AUBAGIO (Drug) $260.63
- GOCOVRI (Drug) $251.02
- SPRIX (Drug) $227.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Stuart
Dr. Sunil Chauhan, Md, MD
Neurology — Payments: $70,847
Dr. Lara Fix, Do, DO
Neurology — Payments: $20,772
Henry Calas, Md, MD
Neurology — Payments: $20,459
Paul Elliott, Do, DO
Neurology — Payments: $19,557
Alyssa Starek, Pa, PA
Neurology — Payments: $8,458
Joshua Leibner, M.d, M.D
Neurology — Payments: $2,533